Development and Validation of a Prognostic Risk Model for Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors

BACKGROUND: Risk stratification tools for patients with advanced melanoma (AM) treated with immune checkpoint inhibitors (ICI) are lacking. We identified a new prognostic model associated with overall survival (OS). PATIENTS AND METHODS: A total of 318 treatment naïve patients with AM receiving ICI...

Descripción completa

Detalles Bibliográficos
Autores principales: Stukalin, Igor, Navani, Vishal, Gupta, Mehul, Ruan, Yibing, Boyne, Devon J, O’Sullivan, Dylan E, Meyers, Daniel E, Goutam, Siddhartha, Sander, Michael, Ewanchuk, Benjamin W, Brenner, Darren R, Suo, Aleksi, Cheung, Winson Y, Heng, Daniel Y C, Monzon, Jose G, Cheng, Tina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Melanoma and Cutaneous Malignancies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485285/
https://www.ncbi.nlm.nih.gov/pubmed/37011230
http://dx.doi.org/10.1093/oncolo/oyad073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485285/
https://www.ncbi.nlm.nih.gov/pubmed/37011230
http://dx.doi.org/10.1093/oncolo/oyad073

Ejemplares similares